Format

Send to

Choose Destination
J Clin Endocrinol Metab. 2000 Sep;85(9):3431-5.

Heterogeneity of nuclear lamin A mutations in Dunnigan-type familial partial lipodystrophy.

Author information

1
Robarts Research Institute and Department of Medicine, University of Western Ontario, London, Canada. robert.hegele@rri.on.ca

Abstract

We previously identified a novel mutation, namely LMNA R482Q, that was found to underlie Dunnigan-type partial lipodystrophy (FPLD) and diabetes in an extended Canadian kindred. We have since sequenced LMNA in five additional Canadian FPLD probands and herein report three new rare missense mutations in LMNA: V440M, R482W, and R584H. One severely affected subject was a compound heterozygote for both V440M and R482Q. The findings indicated that 1) a spectrum of LMNA mutations underlies FPLD; 2) aberrant lamin A, and not lamin C, is likely to underlie FPLD, as R584H occurs within LMNA sequence that is specific for lamin A; 3) the V440M mutation may not cause lipodystrophy on its own; 4) compound heterozygosity for V440M and R482Q is associated with a relatively more severe FPLD phenotype, but not with complete lipodystrophy; and 5) variation in the severity of the phenotype might be related to environmental factors.

PMID:
10999845
DOI:
10.1210/jcem.85.9.6822
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center